NKTR Financial Statements

Balance sheet, income statement, cash flow, and dividends for Nektar Therapeutics (NKTR).


$171.55M Market Cap.

As of 03/14/2025 5:00 PM ET (MRY) • Disclaimer

NKTR Market Cap. (MRY)


NKTR Shares Outstanding (MRY)


NKTR Assets (MRY)


Total Assets

$303.85M

Total Liabilities

$243.11M

Total Investments

$237.06M

NKTR Income (MRY)


Revenue

$98.43M

Net Income

-$118.96M

Operating Expense

$172.94M

NKTR Cash Flow (MRY)


CF Operations

-$175.71M

CF Investing

$142.57M

CF Financing

$42.12M

NKTR Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

NKTR Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$303,850,000 (-23.66%)

$398,033,000 (-43.99%)

$710,600,000 (-36.39%)

$1,117,189,000 (-27.40%)

Assets Current

$261,292,000 (-20.99%)

$330,701,000 (-39.43%)

$545,968,000 (-31.37%)

$795,581,000 (-30.09%)

Assets Non-Current

$42,558,000 (-36.79%)

$67,332,000 (-59.10%)

$164,632,000 (-48.81%)

$321,608,000 (-19.75%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$76,501,000 (0.00%)

$76,501,000 (0.00%)

Shareholders Equity

$60,737,000 (-53.63%)

$130,987,000 (-64.27%)

$366,638,000 (-46.04%)

$679,508,000 (-36.92%)

Property Plant & Equipment Net

$11,824,000 (-67.92%)

$36,863,000 (-57.08%)

$85,886,000 (-51.62%)

$177,535,000 (-4.62%)

Cash & Equivalents

$44,252,000 (25.44%)

$35,277,000 (-60.02%)

$88,227,000 (249.86%)

$25,218,000 (-87.32%)

Accumulated Other Comprehensive Income

$61,000 (-23.75%)

$80,000 (101.16%)

-$6,907,000 (-66.15%)

-$4,157,000 (-81.13%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$237,061,000 (-19.41%)

$294,164,000 (-29.41%)

$416,750,000 (-46.13%)

$773,565,000 (-22.61%)

Investments Current

$210,974,000 (-21.38%)

$268,339,000 (-35.61%)

$416,750,000 (-41.20%)

$708,737,000 (-17.87%)

Investments Non-Current

$26,087,000 (1.01%)

$25,825,000 (0%)

$0 (0%)

$64,828,000 (-52.56%)

Inventory

$0 (0%)

$16,101,000 (-16.15%)

$19,202,000 (21.52%)

$15,801,000 (3.33%)

Trade & Non-Trade Receivables

$0 (0%)

$1,205,000 (-79.85%)

$5,981,000 (-73.41%)

$22,492,000 (-42.16%)

Trade & Non-Trade Payables

$11,560,000 (17.38%)

$9,848,000 (-24.13%)

$12,980,000 (33.17%)

$9,747,000 (-55.97%)

Accumulated Retained Earnings (Deficit)

-$3,596,210,000 (-3.42%)

-$3,477,249,000 (-8.62%)

-$3,201,193,000 (-13.00%)

-$2,832,995,000 (-22.69%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$102,564,000 (-12.92%)

$117,776,000 (-10.43%)

$131,496,000 (-8.16%)

$143,177,000 (-4.73%)

Debt Current

$19,868,000 (3.16%)

$19,259,000 (3.17%)

$18,667,000 (7.03%)

$17,441,000 (25.34%)

Debt Non-Current

$82,696,000 (-16.06%)

$98,517,000 (-12.68%)

$112,829,000 (-10.27%)

$125,736,000 (-7.80%)

Total Liabilities

$243,113,000 (-8.96%)

$267,046,000 (-22.36%)

$343,962,000 (-21.41%)

$437,681,000 (-5.16%)

Liabilities Current

$61,400,000 (19.76%)

$51,269,000 (-24.83%)

$68,204,000 (-19.95%)

$85,200,000 (-26.41%)

Liabilities Non-Current

$181,713,000 (-15.79%)

$215,777,000 (-21.75%)

$275,758,000 (-21.77%)

$352,481,000 (1.96%)

NKTR Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$98,427,000 (9.22%)

$90,122,000 (-2.10%)

$92,055,000 (-9.67%)

$101,907,000 (-33.36%)

Cost of Revenue

$30,686,000 (-9.13%)

$33,768,000 (56.08%)

$21,635,000 (-13.10%)

$24,897,000 (27.83%)

Selling General & Administrative Expense

$76,751,000 (-0.86%)

$77,417,000 (-16.15%)

$92,333,000 (-24.84%)

$122,844,000 (17.35%)

Research & Development Expense

$120,908,000 (5.91%)

$114,162,000 (-47.71%)

$218,323,000 (-45.46%)

$400,269,000 (-2.06%)

Operating Expenses

$172,939,000 (-45.96%)

$320,038,000 (-28.34%)

$446,586,000 (-14.63%)

$523,113,000 (-6.34%)

Interest Expense

$28,112,000 (10.97%)

$25,334,000 (-12.37%)

$28,911,000 (-38.89%)

$47,313,000 (27.47%)

Income Tax Expense

-$239,000 (-19.50%)

-$200,000 (-106.22%)

$3,215,000 (477.20%)

$557,000 (12.98%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$118,961,000 (56.91%)

-$276,056,000 (25.03%)

-$368,198,000 (29.71%)

-$523,837,000 (-17.86%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$118,961,000 (56.91%)

-$276,056,000 (25.03%)

-$368,198,000 (29.71%)

-$523,837,000 (-17.86%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$118,961,000 (56.91%)

-$276,056,000 (25.03%)

-$368,198,000 (29.71%)

-$523,837,000 (-17.86%)

Weighted Average Shares

$205,661,000 (8.24%)

$190,001,000 (1.53%)

$187,138,000 (2.09%)

$183,298,000 (2.64%)

Weighted Average Shares Diluted

$205,661,000 (8.24%)

$190,001,000 (1.53%)

$187,138,000 (2.09%)

$183,298,000 (2.64%)

Earning Before Interest & Taxes (EBIT)

-$91,088,000 (63.70%)

-$250,922,000 (25.34%)

-$336,072,000 (29.39%)

-$475,967,000 (-16.99%)

Gross Profit

$67,741,000 (20.21%)

$56,354,000 (-19.97%)

$70,420,000 (-8.56%)

$77,010,000 (-42.29%)

Operating Income

-$105,198,000 (60.10%)

-$263,684,000 (29.90%)

-$376,166,000 (15.68%)

-$446,103,000 (-4.94%)

NKTR Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$142,570,000 (2.15%)

$139,564,000 (-61.85%)

$365,835,000 (80.41%)

$202,777,000 (-59.14%)

Net Cash Flow from Financing

$42,118,000 (140293.33%)

$30,000 (-98.01%)

$1,508,000 (-95.84%)

$36,238,000 (145.10%)

Net Cash Flow from Operations

-$175,709,000 (8.77%)

-$192,606,000 (36.64%)

-$304,007,000 (26.33%)

-$412,660,000 (-31.72%)

Net Cash Flow / Change in Cash & Cash Equivalents

$8,975,000 (116.95%)

-$52,950,000 (-184.04%)

$63,009,000 (136.27%)

-$173,737,000 (-269.35%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$78,652,000 (-43.49%)

$139,184,000 (-61.16%)

$358,315,000 (64.54%)

$217,766,000 (-56.75%)

Capital Expenditure

$63,918,000 (16720.53%)

$380,000 (-94.95%)

$7,520,000 (150.17%)

-$14,989,000 (-106.52%)

Issuance (Repayment) of Debt Securities

$15,000,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

-$2,882,000 (-9706.67%)

$30,000 (-96.04%)

$758,000 (-97.72%)

$33,238,000 (42.07%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$4,000 (-106.45%)

$62,000 (118.96%)

-$327,000 (-255.43%)

-$92,000 (-560.00%)

Share Based Compensation

$21,612,000 (-35.27%)

$33,388,000 (-41.75%)

$57,320,000 (-39.46%)

$94,674,000 (0.44%)

Depreciation Amortization & Accretion

$4,391,000 (-43.81%)

$7,815,000 (-40.02%)

$13,030,000 (-7.89%)

$14,146,000 (-0.25%)

NKTR Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

68.80% (10.08%)

62.50% (-18.30%)

76.50% (1.19%)

75.60% (-13.40%)

Profit Margin

-120.90% (60.53%)

-306.30% (23.42%)

-400.00% (22.18%)

-514.00% (-76.88%)

EBITDA Margin

-88.10% (67.35%)

-269.80% (23.11%)

-350.90% (22.57%)

-453.20% (-76.48%)

Return on Average Equity (ROAE)

-150.60% (0.66%)

-151.60% (-89.97%)

-79.80% (-28.71%)

-62.00% (-67.57%)

Return on Average Assets (ROAA)

-35.20% (39.52%)

-58.20% (-33.49%)

-43.60% (-8.73%)

-40.10% (-47.43%)

Return on Sales (ROS)

-92.50% (66.77%)

-278.40% (23.75%)

-365.10% (21.84%)

-467.10% (-75.60%)

Return on Invested Capital (ROIC)

-26.10% (49.42%)

-51.60% (-11.93%)

-46.10% (-12.44%)

-41.00% (-46.43%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.6 (-311.03%)

-0.39 (66.00%)

-1.15 (75.72%)

-4.72 (30.80%)

Price to Sales Ratio (P/S)

1.94 (63.14%)

1.19 (-74.07%)

4.59 (-81.09%)

24.3 (22.40%)

Price to Book Ratio (P/B)

2.82 (243.13%)

0.82 (-28.99%)

1.16 (-68.41%)

3.67 (29.60%)

Debt to Equity Ratio (D/E)

4 (96.32%)

2.04 (117.38%)

0.94 (45.65%)

0.64 (50.47%)

Earnings Per Share (EPS)

-0.58 (60.00%)

-1.45 (26.40%)

-1.97 (31.12%)

-2.86 (-14.86%)

Sales Per Share (SPS)

0.48 (1.05%)

0.47 (-3.66%)

0.49 (-11.51%)

0.56 (-35.05%)

Free Cash Flow Per Share (FCFPS)

-0.54 (46.25%)

-1.01 (36.11%)

-1.58 (32.10%)

-2.33 (-29.97%)

Book Value Per Share (BVPS)

0.29 (-57.18%)

0.69 (-64.83%)

1.96 (-47.15%)

3.71 (-38.55%)

Tangible Assets Book Value Per Share (TABVPS)

1.48 (-29.50%)

2.1 (-38.16%)

3.39 (-40.33%)

5.68 (-30.65%)

Enterprise Value Over EBIT (EV/EBIT)

-3 (-200.00%)

-1 (0.00%)

-1 (80.00%)

-5 (37.50%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.88 (-326.67%)

-0.68 (51.92%)

-1.4 (74.92%)

-5.6 (30.17%)

Asset Turnover

0.29 (53.16%)

0.19 (74.31%)

0.11 (39.74%)

0.08 (-17.02%)

Current Ratio

4.26 (-34.02%)

6.45 (-19.43%)

8.01 (-14.28%)

9.34 (-5.00%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$111,791,000 (41.84%)

-$192,226,000 (35.17%)

-$296,487,000 (30.67%)

-$427,649,000 (-33.41%)

Enterprise Value (EV)

$249,699,204 (52.11%)

$164,152,370 (-63.82%)

$453,672,129 (-82.46%)

$2,585,807,745 (-17.87%)

Earnings Before Tax (EBT)

-$119,200,000 (56.85%)

-$276,256,000 (24.31%)

-$364,983,000 (30.25%)

-$523,280,000 (-17.87%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$86,697,000 (64.34%)

-$243,107,000 (24.74%)

-$323,042,000 (30.05%)

-$461,821,000 (-17.62%)

Invested Capital

$300,762,000 (-29.94%)

$429,263,000 (-29.53%)

$609,164,000 (-43.25%)

$1,073,447,000 (-17.29%)

Working Capital

$199,892,000 (-28.46%)

$279,432,000 (-41.51%)

$477,764,000 (-32.75%)

$710,381,000 (-30.51%)

Tangible Asset Value

$303,850,000 (-23.66%)

$398,033,000 (-37.23%)

$634,099,000 (-39.07%)

$1,040,688,000 (-28.83%)

Market Capitalization

$171,546,204 (59.16%)

$107,785,370 (-74.63%)

$424,777,129 (-82.96%)

$2,493,366,745 (-18.24%)

Average Equity

$79,003,500 (-56.60%)

$182,044,500 (-60.54%)

$461,370,500 (-45.41%)

$845,132,250 (-29.59%)

Average Assets

$337,790,500 (-28.75%)

$474,074,750 (-43.86%)

$844,427,250 (-35.32%)

$1,305,586,000 (-20.03%)

Invested Capital Average

$349,627,000 (-28.15%)

$486,610,000 (-33.29%)

$729,392,250 (-37.16%)

$1,160,791,000 (-20.14%)

Shares

184,458,284 (-3.31%)

190,770,566 (1.50%)

187,954,482 (1.84%)

184,557,124 (2.88%)